209 related articles for article (PubMed ID: 10029067)
1. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
Lin H; Huber R; Schlessinger D; Morin PJ
Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
[TBL] [Abstract][Full Text] [Related]
2. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma.
Murthy SS; Shen T; De Rienzo A; Lee WC; Ferriola PC; Jhanwar SC; Mossman BT; Filmus J; Testa JR
Oncogene; 2000 Jan; 19(3):410-6. PubMed ID: 10656689
[TBL] [Abstract][Full Text] [Related]
3. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
4. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.
Pilia G; Hughes-Benzie RM; MacKenzie A; Baybayan P; Chen EY; Huber R; Neri G; Cao A; Forabosco A; Schlessinger D
Nat Genet; 1996 Mar; 12(3):241-7. PubMed ID: 8589713
[TBL] [Abstract][Full Text] [Related]
5. Glypican-3 expression is silenced in human breast cancer.
Xiang YY; Ladeda V; Filmus J
Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870
[TBL] [Abstract][Full Text] [Related]
6. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
Xuan JY; Hughes-Benzie RM; MacKenzie AE
J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
[TBL] [Abstract][Full Text] [Related]
7. GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13.
Paine-Saunders S; Viviano BL; Saunders S
Genomics; 1999 May; 57(3):455-8. PubMed ID: 10329016
[TBL] [Abstract][Full Text] [Related]
8. Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families.
Hughes-Benzie RM; Pilia G; Xuan JY; Hunter AG; Chen E; Golabi M; Hurst JA; Kobori J; Marymee K; Pagon RA; Punnett HH; Schelley S; Tolmie JL; Wohlferd MM; Grossman T; Schlessinger D; MacKenzie AE
Am J Med Genet; 1996 Dec; 66(2):227-34. PubMed ID: 8958336
[TBL] [Abstract][Full Text] [Related]
9. Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain.
Saunders S; Paine-Saunders S; Lander AD
Dev Biol; 1997 Oct; 190(1):78-93. PubMed ID: 9331333
[TBL] [Abstract][Full Text] [Related]
10. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
Chiao E; Fisher P; Crisponi L; Deiana M; Dragatsis I; Schlessinger D; Pilia G; Efstratiadis A
Dev Biol; 2002 Mar; 243(1):185-206. PubMed ID: 11846487
[TBL] [Abstract][Full Text] [Related]
11. Simpson Golabi Behmel syndrome: progress toward understanding the molecular basis for overgrowth, malformation, and cancer predisposition.
DeBaun MR; Ess J; Saunders S
Mol Genet Metab; 2001 Apr; 72(4):279-86. PubMed ID: 11286501
[TBL] [Abstract][Full Text] [Related]
12. Overgrowth syndromes and genomic imprinting: from mouse to man.
Li M; Squire JA; Weksberg R
Clin Genet; 1998 Mar; 53(3):165-70. PubMed ID: 9630066
[TBL] [Abstract][Full Text] [Related]
13. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
14. Glypican 3: a novel marker in testicular germ cell tumors.
Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation in transcriptional repression of two differentially expressed X-linked genes, GPC3 and SYBL1.
Huber R; Hansen RS; Strazzullo M; Pengue G; Mazzarella R; D'Urso M; Schlessinger D; Pilia G; Gartler SM; D'Esposito M
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):616-21. PubMed ID: 9892682
[TBL] [Abstract][Full Text] [Related]
16. A clinical and molecular study of a patient with Simpson-Golabi-Behmel syndrome.
Okamoto N; Yagi M; Imura K; Wada Y
J Hum Genet; 1999; 44(5):327-9. PubMed ID: 10496077
[TBL] [Abstract][Full Text] [Related]
17. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
[TBL] [Abstract][Full Text] [Related]
18. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
Cano-Gauci DF; Song HH; Yang H; McKerlie C; Choo B; Shi W; Pullano R; Piscione TD; Grisaru S; Soon S; Sedlackova L; Tanswell AK; Mak TW; Yeger H; Lockwood GA; Rosenblum ND; Filmus J
J Cell Biol; 1999 Jul; 146(1):255-64. PubMed ID: 10402475
[TBL] [Abstract][Full Text] [Related]
19. Glypican 3 and glypican 4 are juxtaposed in Xq26.1.
Huber R; Mazzarella R; Chen CN; Chen E; Ireland M; Lindsay S; Pilia G; Crisponi L
Gene; 1998 Dec; 225(1-2):9-16. PubMed ID: 9931407
[TBL] [Abstract][Full Text] [Related]
20. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]